Autocrine Motility Factor Receptor Signaling Pathway Promotes Cell Invasion via Activation of ROCK-2 in Esophageal Squamous Cell Cancer Cells

REFERENCES

• Katiyar, S.; Hedau, S.; Jain, N.; Kar, P.; Khuroo, M.S.; Mohanta, J.; Kumar, S.; Gopalkrishna, V.; Kumar, N.; Das, B.C. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005, 218(1), 69–79.
   PubMed Web of Science ®Google Scholar
• Whibley, C.E.; Keyzers, R.A.; Soper, A.G.; Davies-Coleman, M.T.; Samaai, T.; Hendricks, D.T. Antiesophageal cancer activity from Southern African marine organisms. Ann NY Acad Sci 2005, 1056, 405–412.
   PubMed Web of Science ®Google Scholar
• Montesano, R.; Hollstein, M.; Hainaut, P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996, 69(3), 225–235.
   PubMed Web of Science ®Google Scholar
• Iiizumi, M.; Liu, W.; Pai, S.K.; Furuta, E.; Watabe, K. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta 2008, 1786(2), 87–104.
   PubMed Web of Science ®Google Scholar
• Yanagawa, T.; Funasaka, T.; Tsutsumi, S.; Hu, H.; Watanabe, H.; Raz, A. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14. Cancer Res 2007, 67(18), 8682–8689.
   PubMed Web of Science ®Google Scholar
• Shimizu, K.; Tani, M.; Watanabe, H.; Nagamachi, Y.; Niinaka, Y.; Shiroishi, T.; Ohwada, S.; Raz, A.; Yokota, J. The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett 1999, 456(2), 295–300.
   PubMed Web of Science ®Google Scholar
• Wang, W.; Yang, L.Y.; Yang, Z.L.; Peng, J.X.; Yang, J.Q. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma. Dig Dis Sci 2007, 52(3), 770–775.
   PubMed Web of Science ®Google Scholar
• Kawanishi, K.; Doki, Y.; Shiozaki, H.; Yano, M.; Inoue, M.; Fukuchi, N.; Utsunomiya, T.; Watanabe, H.; Monden, M. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers. Am J Clin Pathol 2000, 113(2), 266–274.
   PubMed Web of Science ®Google Scholar
• Kaynak, K.; Kara, M.; Oz, B.; Akgoz, B.; Sar, M.; Raz, A. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas. Acta Chir Belg 2005, 105(4), 378–382.
   PubMed Web of Science ®Google Scholar
• Jiang, W.G.; Raz, A.; Douglas-Jones, A.; Mansel, R.E. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer. J Histochem Cytochem 2006, 54(2), 231–241.
   PubMed Web of Science ®Google Scholar
• Torimura, T.; Ueno, T.; Kin, M.; Harada, R.; Nakamura, T.; Kawaguchi, T.; Harada, M.; Kumashiro, R.; Watanabe, H.; Avraham, R.; Sata, M. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins. Hepatology 2001, 34(1), 62–71.
   PubMed Web of Science ®Google Scholar
• Le, P.U.; Benlimame, N.; Lagana, A.; Raz, A.; Nabi, I.R. Clathrin-mediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility. J Cell Sci 2000, 113(Pt. 18), 3227–3240.
   PubMed Web of Science ®Google Scholar
• Onishi, Y.; Tsukada, K.; Yokota, J.; Raz, A. Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation. Clin Exp Metastasis 2003, 20(1), 51–58.
   PubMed Web of Science ®Google Scholar
• Tímár, J.; Rásó, E.; Döme, B.; Ladányi, A.; Bánfalvi, T.; Gilde, K.; Raz, A. Expression and function of the AMF receptor by human melanoma in experimental and clinical systems. Clin Exp Metastasis 2002, 19(3), 225–232.
   PubMed Web of Science ®Google Scholar
• Tian, F.; Zang, W.D.; Hou, W.H.; Liu, H.T.; Xue, L.X. Nuclear factor-κB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin 2006, 38(5), 318–326.
   Google Scholar
• Hou, G.Q.; Xue, L.X.; Lu, Z.M.; Fan, T.L.; Tian, F.; Xue, Y.L. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett 2007, 253(2), 236–248.
   PubMed Web of Science ®Google Scholar
• Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• Shimada, T.; Nishimura, Y.; Nishiuma, T.; Rikitake, Y.; Hirase, T.; Yokoyama, M. Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci 2007, 53(3), 125–34.
   PubMedGoogle Scholar
• Rösel, D.; Brábek, J.; Tolde, O.; Mierke, C.T.; Zitterbart, D.P.;Raupach, C.; Bicanová, K.; Kollmannsberger, P.; Panková, D.; Vesely, P.; Folk, P.; Fabry, B. Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 2008, 6(9), 1410–1420.
   PubMed Web of Science ®Google Scholar
• Xue, F.; Takahara, T.; Yata, Y.; Xia, Q.; Nonome, K.; Shinno, E.; Kanayama, M.; Takahara, S.; Sugiyama, T. Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner. Hepatol Res 2008, 38(8), 810–817.
   PubMed Web of Science ®Google Scholar
• Vishnubhotla, R.; Sun, S.; Huq, J.; Bulic, M.; Ramesh, A.; Guzman, G.; Cho, M.; Glover, S.C. ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 2007, 87(11), 1149–1158.
   PubMed Web of Science ®Google Scholar
• Lane, J.; Martin, T.A.; Watkins, G.; Mansel, R.E.; Jiang, W.G. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 2008, 33(3), 585–593.
   PubMed Web of Science ®Google Scholar
• Jiang, P.; Enomoto, A.; Takahashi, M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett 2009, 284(2), 122–130.
   PubMed Web of Science ®Google Scholar
• Wang, W.; Goswami, S.; Sahai, E.; Wyckoff, J.B.; Segall, J.E.; Condeelis, J.S. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005, 15(3), 138–145.
   PubMed Web of Science ®Google Scholar
• Borley, A.C.; Hiscox, S.; Gee, J.; Smith, C.; Shaw, V.; Barrett-Lee, P.; Nicholson, R.I. Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells. Breast Cancer Res 2008, 10(6), R103.
   PubMed Web of Science ®Google Scholar
• Kawanishi, K.; Doki, Y.; Shiozaki, H.; Yano, M.; Inoue, M.; Fukuchi, N.; Utsunomiya, T.; Watanabe, H.; Monden, M. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers. Am J Clin Pathol 2000, 113(2),266–274.
   PubMed Web of Science ®Google Scholar
• Coskun, U.; Sancak, B.; Sen, I.; Bukan, N.; Tufan, M.A.; Gülbahar, O.; Sozen, S. Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages. Int Immunopharmacol 2006, 6(4), 672–677.
   PubMed Web of Science ®Google Scholar